Synbiotics

HeiQ unveils HeiQ Skin Care - a probiotics-infused textile technology

Retrieved on: 
Tuesday, November 21, 2023
ISPO, Diet, Acne, Nutritional science, Sleep, Synbiotics, Hormone, Radiation, Gene, Psoriasis, Dermatitis, Irritation, Textile, Leisure, Probiotic, Ageing, HeiQ Materials AG, Rosacea, Red, Skin, Sport, Overalls, Thought, Cosmetics, Smoking, Dietary supplement

HeiQ, a global leader in textile innovation, is proud to announce the launch of HeiQ Skin Care technology for next-to-skin apparel and home textiles.

Key Points: 
  • HeiQ, a global leader in textile innovation, is proud to announce the launch of HeiQ Skin Care technology for next-to-skin apparel and home textiles.
  • HeiQ Skin Care is a synbiotic textile finish aimed at providing a balanced microbiome for glowing skin, even after repeated use and washing of textiles.
  • "HeiQ Skin Care represents a leap forward in textile innovation, combining the power of probiotics and prebiotics to enhance skin microbiome and overall skin appearance.
  • HeiQ Skin Care is suitable for all textile fibers, both natural and synthetic, and can be applied to all textile items that come in direct contact with the skin.

HeiQ unveils HeiQ Skin Care - a probiotics-infused textile technology

Retrieved on: 
Tuesday, November 21, 2023
ISPO, Diet, Acne, Nutritional science, Sleep, Synbiotics, Hormone, Radiation, Gene, Psoriasis, Dermatitis, Irritation, Textile, Leisure, Probiotic, Ageing, HeiQ Materials AG, Rosacea, Red, Skin, Sport, Overalls, Thought, Cosmetics, Smoking, Dietary supplement

HeiQ, a global leader in textile innovation, is proud to announce the launch of HeiQ Skin Care technology for next-to-skin apparel and home textiles.

Key Points: 
  • HeiQ, a global leader in textile innovation, is proud to announce the launch of HeiQ Skin Care technology for next-to-skin apparel and home textiles.
  • HeiQ Skin Care is a synbiotic textile finish aimed at providing a balanced microbiome for glowing skin, even after repeated use and washing of textiles.
  • "HeiQ Skin Care represents a leap forward in textile innovation, combining the power of probiotics and prebiotics to enhance skin microbiome and overall skin appearance.
  • HeiQ Skin Care is suitable for all textile fibers, both natural and synthetic, and can be applied to all textile items that come in direct contact with the skin.

EQS-News: Multi-entrepreneur Frank Otto invests in SynBiotic SE: The Munich-based company acquires majority stake in CannaCare Health and appoints Daniel Kruse as CEO

Retrieved on: 
Tuesday, August 22, 2023
European Industrial Hemp Association, MH, Gesellschaft mit beschränkter Haftung, Kruse, Hemp, VIVA, Federation, Acquisition, EIHA, CBD, Cannabis, SE, Multi, Synbiotics, Management, Security (finance), Drug

Multi-entrepreneur Frank Otto invests in SynBiotic SE: The Munich-based company acquires majority stake in CannaCare Health and appoints Daniel Kruse as CEO

Key Points: 
  • Multi-entrepreneur Frank Otto invests in SynBiotic SE: The Munich-based company acquires majority stake in CannaCare Health and appoints Daniel Kruse as CEO
    The issuer is solely responsible for the content of this announcement.
  • Multi-entrepreneur Frank Otto invests in SynBiotic SE:
    Hemp pioneer Daniel Kruse joins SynBiotic management as CEO.
  • As part of the acquisition, investor and CannaCare shareholder Frank Otto invests three million euros in SynBiotic SE through an extensive share package.
  • Frank Otto on his investment: "For me, SynBiotic SE is the future of the European cannabis industry.

Sun Genomics Appoints Vice President of Sales and Business Development

Retrieved on: 
Tuesday, May 16, 2023
Partnership, American Academy of Anti-Aging Medicine, Arizona State University, Spectrum, Genomics, The Biodesign Institute, Synbiotics, Quality of life, American Academy, Research, A4M, Patient, ASD, SAN, Happiness, Fonterra, Knowledge, Yung Bleu, Health, Probiotic, Mental health, Pharmaceutical industry

SAN DIEGO, May 16, 2023 (GLOBE NEWSWIRE) -- Sun Genomics, a leader in gut health testing that specializes in made-to-order probiotics based on an individual’s gut microflora, continues to strategically expand its brand and clinical offerings with the appointment of Will Hankee as vice president of sales and business development.

Key Points: 
  • SAN DIEGO, May 16, 2023 (GLOBE NEWSWIRE) -- Sun Genomics, a leader in gut health testing that specializes in made-to-order probiotics based on an individual’s gut microflora, continues to strategically expand its brand and clinical offerings with the appointment of Will Hankee as vice president of sales and business development.
  • There, he grew the organization’s clinical presence of diagnostic testing on a global scale and has a proven sales leadership background focused on developing high-performing technical sales teams.
  • Sun Genomics will also exhibit at A4M The Fire Inside , taking place from May 18-20 in Orlando, FL.
  • For more information on Sun Genomics or Floré, the world’s only fully customized probiotic, visit www.flore.com .

SupplySide East 2023 Welcomes Many First-Time & International Attendees as Thriving Health & Nutrition Industry Continues to Innovate and Grow

Retrieved on: 
Friday, April 21, 2023
Town, Food, Drink, Education, Probiotic, Gelita, Printing, CPG, University, Tree, Ageing, Synbiotics, Science, Children & Nature Network, Organization, Expo, Student, The Plaza at Harmon Meadow, Dietary supplement, Withania somnifera, RPET, Women's health, Health, Woman, Content, Nightclub

New this year, SupplySide partnered with Naturally Network to host 20 first-time visitors who are part of the Naturally Network minority-owned fellowship program.

Key Points: 
  • New this year, SupplySide partnered with Naturally Network to host 20 first-time visitors who are part of the Naturally Network minority-owned fellowship program.
  • The number of international attendees also rose, with 13 percent of attendees coming from 36 countries, an increase from prior years.
  • Industry members who were unable to attend these sessions can access them on-demand through NaturalProductsInsider.com and within the SupplySide East mobile app.
  • "Attending SupplySide East is key to building relationships that are more likely to lead to valuable business opportunities.

The Global Prebiotic Association Announces 2023 Young Researcher Fundamental and Applied Research Grant Winners

Retrieved on: 
Friday, April 21, 2023
Single, University, Toll-like receptor, GPA, Synbiotics, Research, Doctor of Philosophy, Groningen, Nutritional science, Journal, Research fellow, University of Groningen, Applied science, Fundamental, Toll, University Medical Center Groningen, Woman, Carbohydrate Polymers, Pharmaceutical industry

CHICAGO, April 21, 2023 /PRNewswire/ -- The Global Prebiotic Association, the only global trade association serving as a resource for prebiotic education, insights, and awareness building, announced today its 2023 Young Researcher grant recipients.

Key Points: 
  • CHICAGO, April 21, 2023 /PRNewswire/ -- The Global Prebiotic Association, the only global trade association serving as a resource for prebiotic education, insights, and awareness building, announced today its 2023 Young Researcher grant recipients.
  • Grants were awarded in two categories – Fundamental and Applied Research.
  • Topics could cover any aspect of prebiotic research (primary authorship) including gut and other microbiomes and must have been original research published in a peer-reviewed journal.
  • The 2024 grant application period will open in November 2023 and will be open to researchers covering prebiotics and synbiotics.

ADM and Brightseed Launch Global Partnership To Decode How The Gut Microbiome & Bioactives Impact Human Health

Retrieved on: 
Thursday, April 6, 2023
Retail, Other Health, Technology, Artificial Intelligence, Fitness & Nutrition, Agriculture, Natural Resources, Specialty, Vitamins, Supplements, Biotechnology, Science, Software, Other Science, Food, Beverage, Research, Health, ADM, Partnership, Diet, Drink, A.I, Synbiotics, Multimedia, Global health, Nutritional science, Plant, Gut–brain axis, Dietary supplement, Biology, Bacteria, Probiotic

ADM , a global leader in nutrition that powers many of the world’s top food, beverage, and health and wellness brands, and Brightseed , the bioactives company and a World Economic Forum Global Innovator, today announced a global joint partnership to develop evidence-based functional synbiotic products that target microbiome optimization with an undisclosed investment.

Key Points: 
  • ADM , a global leader in nutrition that powers many of the world’s top food, beverage, and health and wellness brands, and Brightseed , the bioactives company and a World Economic Forum Global Innovator, today announced a global joint partnership to develop evidence-based functional synbiotic products that target microbiome optimization with an undisclosed investment.
  • platform, Forager®, to decipher the molecular interactions between dietary plants and gut microbes, and their potential impact on human health.
  • View the full release here: https://www.businesswire.com/news/home/20230406005144/en/
    ADM and Brightseed Launch Global Partnership to Decode How The Gut Microbiome and Bioactives Impact Human Health (Photo: Business Wire)
    “We know from our recent research into global consumer trends that macro forces, including the lingering pandemic, have coincided with an increased demand for natural and plant-based solutions that target immune function, metabolic health, and mental well-being,” said Mark Lotsch, ADM’s president of global health and wellness.
  • ADM and Brightseed aim to launch highly efficacious synbiotics in specific health areas as functional ingredients for foods and beverages, dietary supplements, and medical foods by 2025.

EQS-News: SynBiotic SE attracts Canopy Growth founder Bruce Linton as Chairman of newly created Advisory Board

Retrieved on: 
Sunday, November 27, 2022
Marketing, Union, TSX, Advisory board, Pain, ASX, SE, Sleep deprivation, Anxiety, NYSE, Canopy Growth, Research, CSE, News, Synbiotics, CAD, Security (finance), Drug

SynBiotic SE, (SBX.DE) one of Germanys leading cannabinoid companies, accelerates implementation of the operational platform to achieve market leadership in the upcoming national legalization of recreational cannabis by securing Bruce Linton to its team.

Key Points: 
  • SynBiotic SE, (SBX.DE) one of Germanys leading cannabinoid companies, accelerates implementation of the operational platform to achieve market leadership in the upcoming national legalization of recreational cannabis by securing Bruce Linton to its team.
  • Canopy was the first North American supplier to the German medical cannabis market.
  • Mr. Linton has been appointed as Chairman of SynBiotics newly created Advisory Board and has invested capital in the companys most recent financing round.
  • Lars Mller, CEO of SynBiotic SE, states: The fact that we are working with Bruce Linton is a true accolade.

EQS-News: SynBiotic SE completes successfully capital increase and places all new shares

Retrieved on: 
Monday, October 31, 2022
Marketing, Pain, Synbiotics, Research, EU, SE, Company, News, Cannabis, EUR, Anxiety, Sleep, Security (finance), Drug

SynBiotic SE, as Europe's largest listed group of companies in the hemp and cannabis sector, has successfully completed the cash capital increase resolved on October 28, 2022.

Key Points: 
  • SynBiotic SE, as Europe's largest listed group of companies in the hemp and cannabis sector, has successfully completed the cash capital increase resolved on October 28, 2022.
  • The proceeds from the capital increase will be used to finance the business activities and expansion of SynBiotic SE through acquisitions.
  • SynBiotic SE CEO Lars Mller commented, "The successful closing and full placement of this capital increase demonstrates the great interest in cannabis in Germany and in SynBiotic SE.
  • Together with the capital increase a few weeks ago, we have raised a total of over EUR 4 million in new capital.

EQS-News: SynBiotic SE: “Like winning the lottery” - SynBiotic SE comments on key points paper (“Eckpunktepapier”)

Retrieved on: 
Friday, October 28, 2022
SE, Synbiotics, Legislation, Federation, International law, News, Knowledge, Time, Cannabis, Sale, Security (finance), Drug, Risk management, EU

Regarding the individual points and their respective design, SynBiotic SE sees enormous potential for the various companies in the group and is optimistic about future developments.

Key Points: 
  • Regarding the individual points and their respective design, SynBiotic SE sees enormous potential for the various companies in the group and is optimistic about future developments.
  • CEO of SynBiotic SE Lars Mller says the following: For us, the key points paper and the outstanding regulations presented are like winning the lottery.
  • Regarding the resolutions of the final key points paper, the group sees itself optimally positioned for the most part.
  • Overall, SynBiotic SE classifies the key points paper presented today as an important proposal that is well-developed concerning the majority of the points it addresses, including the details.